… the healthy part of the retina :
Each eye is different, and so is every perception. HOLA automatically determines the eye zone in which the user has the best sharpness and returns the environmental images directly on it.

… the gaze direction :
A text, a face, a landscape, both indoors and outdoors, HOLA detects the nature of the observed objects and adjusts to highlight the most important details. Users can therefore move seamlessly between activities, including those that would otherwise be inaccessible due to their low vision, and so gain autonomy.



… the right images to the right place :
With its image generation technology, HOLA is capable to project real-time environmental images on an optimal part of the eye, by processing and adapting those images to the perception of each patient.

… in « augmented reality » :
The augmented reality is to improve the perception of a real environment, by the addition or modification of details, to make it more relevant.

Thus, a small box connected to the glasses can easily change the brightness and contrast, as well as enlarge images to improve the visual comfort of the user.

Depending on the use, observation conditions and the own characteristics of the pathology to the user, HOLA adapts to provide the best possible user experience.



... people suffering from Age-related macular degeneration (AMD)

Age-related Macular Degeneration (AMD) is a disease of the central part of the retina called the "macula" which can appear from the age of 50 years, and more frequently from 65 years. This disease causes a significant weakening of visual abilities, but does not destroy them. Although some dystrophies affect young people, the term always refers to AMD.

You should know that AMD is the leading cause of blindness in the world and the leading cause of visual impairment in developed countries after the age of 50. It affects about 12% of the population between the ages of 55 and 65 years old to reach 20 to 30% of the population after 65 years old. Every year worldwide, about 500,000 new cases of AMD are diagnosed, and the number of people with the disease could increase by 50% by 2030.